Development and In Vitro Evaluation of Stearic Acid Phosphotyrosine Amide as New Excipient for Zeta Potential Changing Self-Emulsifying Drug Delivery Systems

التفاصيل البيبلوغرافية
العنوان: Development and In Vitro Evaluation of Stearic Acid Phosphotyrosine Amide as New Excipient for Zeta Potential Changing Self-Emulsifying Drug Delivery Systems
المؤلفون: Franz Fischer, Sergey Zaichik, Andreas Bernkop-Schnürch, Christina Leichner, Felix Prüfert
المصدر: Pharmaceutical Research
بيانات النشر: Springer Science and Business Media LLC, 2020.
سنة النشر: 2020
مصطلحات موضوعية: zeta potential changing drug delivery systems, Cell Survival, Surface Properties, Phosphatase, Pharmaceutical Science, Excipient, Conjugated system, phosphatase, Excipients, chemistry.chemical_compound, Drug Delivery Systems, Amide, Stearates, medicine, Zeta potential, Animals, Humans, Pharmacology (medical), Intestinal Mucosa, Pharmacology, Drug Carriers, Chromatography, Organic Chemistry, phosphotyrosine, Amides, chemistry, Emulsifying Agents, Drug delivery, SEDDS, Molecular Medicine, Alkaline phosphatase, Cattle, Emulsions, Stearic acid, Caco-2 Cells, Research Paper, Biotechnology, medicine.drug
الوصف: Abstract Purpose Development of zeta potential changing SEDDS containing newly synthesized derivative stearic acid phosphotyrosine amide. Methods Stearoyl chloride was conjugated with phosphotyrosine, which is substrate for the brush border enzyme intestinal alkaline phosphate. The synthesized derivative was implemented in different SEDDS formulations and the zeta potential changing properties and the concluding mucus diffusion abilities were evaluated. Results Stearic acid phosphotyrosine amide was successfully synthesized and incorporated into SEDDS. A SEDDS formulation containing the new derivative showed a zeta potential of −14 mV before, and + 2 mV after enzymatic cleavage by intestinal alkaline phosphatase. Experiments on a Caco-2 monolayer demonstrated that the phosphate cannot only be cleaved by isolated enzyme, but also by enzyme, which was expressed by cells. The mucus diffusion abilities of the untreated, negatively charged SEDDS were significantly higher compared to the enzymatically cleaved, positively charged SEDDS. Conclusion The developed stearic acid phosphotyrosine represents a promising excipient for zeta potential changing SEDDS.
تدمد: 1573-904X
0724-8741
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1378d3941cef76719384330b19f2b6b6
https://doi.org/10.1007/s11095-020-02802-2
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....1378d3941cef76719384330b19f2b6b6
قاعدة البيانات: OpenAIRE